Press release content from Business Wire. The AP news staff was not involved in its creation.
Athersys Announces Cooperation Agreement With HEALIOS K.K.
February 16, 2021 GMT
CLEVELAND (BUSINESS WIRE) Feb 16, 2021
Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that it has entered into a cooperation agreement with HEALIOS K.K. (“Healios”), the Company’s largest shareholder and one of its commercial partners, and Dr. Hardy TS Kagimoto, a member of the Company’s Board and the Chairman and Chief Executive Officer of Healios. The cooperation agreement is intended to reaffirm the mutual commitment to collaborative development of MultiStem in Japan.
Press release content from Business Wire. The AP news staff was not involved in its creation.
DynCorp International Awarded UH-60 Contractor Logistics Support Services Task Order
February 16, 2021 GMT
GERMANTOWN, Md. (BUSINESS WIRE) Feb 16, 2021
On Dec. 15, the Army Contracting Command, Redstone Arsenal, Alabama, awarded DynCorp International (DI) a task order to provide UH-60 Contractor Logistics Support (CLS) under the Worldwide Logistics Support Services - Contractor Logistics Support (WLSS-C) multiple award IDIQ. This task order, valued at $554.1 million if all options are exercised, consists of a six-year period of performance which includes three months for mobilization, five years of CLS performance with one base year and four option years, and three months for demobilization with a six-month option to extend services.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Red Pine Announces Private Placement and Non-Binding Letter of Intent for a Proposed Reverse Takeover
February 12, 2021 GMT
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / February 12, 2021 / Red Pine Petroleum Ltd. (the “Red Pine” or the “Company”) is pleased to announce the Company has closed a non-brokered private placement of 100,000,000 common shares (each, a “Common Share”) at a price of $0.005 per Common Share for gross proceeds of C$500,000 (the “Offering”).The Company intends to use the net proceeds from the Offering for general working capital purposes. All of the Common Shares issued pursuant to the Offering are subject to a statutory hold period of four months from the date of issuance, in accordance with applicable securities legislation.The TransactionThe Company is also pleased to announce that i